Creative Biogene Launches Advanced mcDNA Production Service: A Game Changer in Gene Therapy

Creative Biogene, a frontrunner in biotechnology solutions, providing cost-effective consumables and reagents, focusing on first generation as well as next-generation sequencing and DNA fragment analysis. Creative Biogene carries a large selection of molecular biology related products, including antibodies, biochemical reagents, cloning kits, enzymes, PCR kits, protein gels & solutions and more. Recently, Creative Biogene is excited to announce the launch of its advanced minicircle DNA (mcDNA) production service with customized and high-quality mcDNA products, ensuring a transformative impact on research and clinical translation.

“Minicircle DNA represents a pivotal shift in gene delivery technology,” says Marcia Brady, the marketing director at Creative Biogene. “As an optimized vector that minimizes potential immune responses while maximizing gene expression, mcDNA positions itself as an ideal choice for researchers and clinicians alike. Our mcDNA production service is engineered to enhance the efficiency and safety of gene therapies, enabling impressive persistence of expression and reduced immunogenicity.”

mcDNA stands as a leading alternative in the field of gene delivery. Unlike traditional plasmid vectors, mcDNA is characterized by its highly efficient gene expression capabilities, with luciferase expression levels reaching up to 10 times those of standard plasmids. Furthermore, mcDNA's unique structural design enables non-integrating delivery, thereby ensuring long-term stable gene expression while significantly reducing the risk of unintended genetic alterations.

Creative Biogene’s mcDNA production services stand apart, distinguished by a comprehensive technical platform, strict adherence to GMP standards, and a sophisticated customization process. From the cloning of genes into suitable parental plasmids to the precise purification of the mcDNA, every stage is meticulously designed to ensure that the final product possesses the utmost purity and functionality. This unwavering commitment to quality is further reinforced by advanced quality control measures—spanning a spectrum ranging from DNA electrophoresis analysis to in-depth, comprehensive stability testing.

Moreover, Creative Biogene’s flexible service options allow for tailored mcDNA production, accommodating both small-scale research initiatives and large-scale clinical applications. This ensures that clients have access to the resources they need at every stage of the therapeutic development process. With extensive experience in process development and GMP manufacturing, Creative Biogene offers integrated services including mcDNA vector design, synthesis, optimization, quality control, stability testing, and GMP production of both non-clinical and clinical-grade mcDNA.

“We have established GMP-compliant platforms to support the production of mcDNA, and our scientists are committed to helping our partners accelerate their groundbreaking work in gene therapy and broader fields,” Marcia Brady added. “With our mcDNA manufacturing services, we aspire to support the development of a new generation of therapies, thereby significantly improving patient outcomes worldwide.”

About Creative Biogene

Creative Biogene is dedicated to providing innovative solutions and comprehensive services for the biotech and pharmaceutical industries. With a team of experienced scientists, Creative Biogene is committed to offering first-rate services to researchers. Creative Biogene takes a tailored approach to customer service, allowing customers to customize project and speak directly with our team of scientists for technical support.